Reference and Interpretive Ranges for α1-Antitrypsin Quantitation by Phenotype in Adult and Pediatric Populations

被引:32
作者
Donato, Leslie J. [1 ]
Jenkins, Sarah M. [2 ]
Smith, Carin [2 ]
Katzmann, Jerry A. [1 ]
Snyder, Melissa R. [1 ]
机构
[1] Mayo Clin, Dept Lab Med & Pathol, Div Clin Biochem & Immunol, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA
关键词
alpha(1)-Antitrypsin; Reference ranges; Reference intervals; Phenotype; Pediatric ranges; OBSTRUCTIVE PULMONARY-DISEASE; ALPHA-1-ANTITRYPSIN DEFICIENCY; MOLECULAR CHARACTERIZATION; VARIANTS; INHIBITOR; DIAGNOSIS; IDENTIFICATION; EMPHYSEMA; ALGORITHM; RISK;
D O I
10.1309/AJCPMEEJK32ACYFP
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Laboratory evaluation of alpha(1)-antitrypsin (A1AT) deficiency involves measurement of circulating A1AT protein (quantitation) and characterization of A1AT genetic polymorphisms (phenotyping or genotyping). This study compared adult and pediatric A1AT reference ranges in patients with nondeficiency alleles and examined AA1AT concentrations in multiple other phenotypes. A1AT phenotype and quantitation were retrospectively collected on adult (n = 21,444) and pediatric (n = 2,469) samples that were submitted for laboratory evaluation of A1AT deficiency. The 95% reference ranges for normal adult and pediatric populations with the M/M phenotype were determined to be 100 to 273 mg/dL (18.4-50.2,mu mol/L) and 93 to 251 mg/dL (17.1-46.2,mu mol/L), respectively (P < .0001). Decreased concentrations of A1AT correlated with heterozygosity and homozygosity for the S and Z alleles in both the adult and pediatric groups. Other rare alleles, such as I, were also associated with decreased concentrations of A1AT, particularly in the context of a Z allele, and may warrant monitoring for symptoms of deficiency.
引用
收藏
页码:398 / 405
页数:8
相关论文
共 32 条
[1]   Detection of alpha-1 antitrypsin deficiency: A review [J].
Aboussouan, Loutfi S. ;
Stoller, James K. .
RESPIRATORY MEDICINE, 2009, 103 (03) :335-341
[3]   Evaluation of an integrative diagnostic algorithm for the identification of people at risk for α1-antitrypsin deficiency [J].
Bornhorst, Joshua A. ;
Procter, Melinda ;
Meadows, Cindy ;
Ashwood, Edward R. ;
Mao, Rong .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 128 (03) :482-490
[4]   Kinetic characterisation of alpha-1-antitrypsin F as an inhibitor of human neutrophil elastase [J].
Cook, L ;
Burdon, JGW ;
Brenton, S ;
Knight, KR ;
Janus, ED .
PATHOLOGY, 1996, 28 (03) :242-247
[5]  
CURIEL DT, 1989, J BIOL CHEM, V264, P10477
[6]   The protease inhibitor PI*S allele and COPD: a meta-analysis [J].
Dahl, M ;
Hersh, CP ;
Ly, NP ;
Berkey, CS ;
Silverman, E ;
Nordestgaard, BG .
EUROPEAN RESPIRATORY JOURNAL, 2005, 26 (01) :67-76
[7]   α1-Antitrypsin deficiency•2:: Genetic aspects of α1-antitrypsin deficiency:: phenotypes and genetic modifiers of emphysema risk [J].
DeMeo, DL ;
Silverman, EK .
THORAX, 2004, 59 (03) :259-264
[8]   DISTRIBUTION OF ALPHA-1-ANTITRYPSIN VARIANTS IN A UNITED-STATES WHITE-POPULATION [J].
DYKES, DD ;
MILLER, SA ;
POLESKY, HF .
HUMAN HEREDITY, 1984, 34 (05) :308-310
[9]   MOLECULAR CHARACTERIZATION OF 3-ALPHA-1-ANTITRYPSIN DEFICIENCY VARIANTS - PROTEINASE-INHIBITOR (PI) NULLCARDIFF (ASP256-]VAL)-PI MMALTON (PHE51-]DELETION) AND PI I (ARG39-]CYS) [J].
GRAHAM, A ;
KALSHEKER, NA ;
NEWTON, CR ;
BAMFORTH, FJ ;
POWELL, SJ ;
MARKHAM, AF .
HUMAN GENETICS, 1989, 84 (01) :55-58
[10]   Chronic obstructive pulmonary disease in α1-antitrypsin PI MZ heterozygotes:: a meta-analysis [J].
Hersh, CP ;
Dahl, M ;
Ly, NP ;
Berkey, CS ;
Nordestgaard, BG ;
Silverman, EK .
THORAX, 2004, 59 (10) :843-849